ProQR Therapeutics NV (PRQR.OQ)
PRQR.OQ on NASDAQ Stock Exchange Global Market
12.48USD
2:35pm EST
12.48USD
2:35pm EST
Change (% chg)
$-0.13 (-1.03%)
$-0.13 (-1.03%)
Prev Close
$12.61
$12.61
Open
$12.56
$12.56
Day's High
$12.63
$12.63
Day's Low
$12.35
$12.35
Volume
27,329
27,329
Avg. Vol
101,058
101,058
52-wk High
$24.00
$24.00
52-wk Low
$2.95
$2.95
Revenue & Earnings Per Share
Revenue* | Earnings Per Share** | ||
---|---|---|---|
FY 2018 | Sep '18 | 2.96 | -0.179 |
Jun '18 | 0.97 | -0.230 | |
Mar '18 | 0.50 | -0.334 | |
FY 2017 | Dec '17 | 0.51 | -0.393 |
Sep '17 | 0.33 | -0.416 | |
Jun '17 | 0.26 | -0.474 | |
Mar '17 | 0.39 | -0.446 |
*Note: Units in Millions ofEuro
**Note: Units in Euro
Consensus Estimates Analysis
# of Estimates | Mean | High | Low | 1 Year Ago | |
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Mar-19 | 3 | 0.90 | 1.60 | 0.00 | -- |
Quarter Ending Jun-19 | 3 | 0.63 | 1.10 | 0.00 | -- |
Year Ending Dec-19 | 5 | 3.84 | 7.50 | 0.00 | 0.00 |
Earnings (per share) | |||||
Quarter Ending Mar-19 | 4 | -0.31 | -0.25 | -0.39 | -- |
Quarter Ending Jun-19 | 4 | -0.33 | -0.30 | -0.40 | -- |
Year Ending Dec-19 | 5 | -1.28 | -1.05 | -1.59 | -1.53 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
Company | industry | sector | ||
---|---|---|---|---|
P/E Ratio (TTM) | -- | 69.44 | 33.70 | |
P/E High - Last 5 Yrs. | -- | 147.79 | 49.87 | |
P/E Low - Last 5 Yrs. | -- | 47.97 | 24.25 | |
Beta | -- | 1.08 | 0.90 | |
Price to Sales (TTM) | 79.24 | 49.51 | 6.29 | |
Price to Book (MRQ) | 2.60 | 10.14 | 5.26 | |
Price to Tangible Book (MRQ) | 2.61 | 13.78 | 6.77 | |
Price to Cash Flow (TTM) | -- | 56.20 | 24.98 | |
% Owned Institutions | 54.62 | 3.74 | 1.69 |
Dividends
Company | industry | sector | ||
---|---|---|---|---|
Dividend Yield | -- | 0.12 | 1.40 | |
Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
Dividend 5 Year Growth Rate | -- | 0.79 | 4.85 | |
Payout Ratio(TTM) | -- | 7.02 | 41.03 |
Growth Rates
Company | industry | sector | ||
---|---|---|---|---|
Sales (MRQ) vs Qtr. 1 Yr. Ago | -55.01 | 206.16 | 12.76 | |
Sales (TTM) vs TTM 1 Yr. Ago | -64.75 | 48.79 | 5.84 | |
Sales - 5 Yr. Growth Rate | -- | 22.76 | 11.23 | |
EPS (MRQ) vs Qtr. 1 Yr. Ago | -11.03 | 75.85 | 47.15 | |
EPS (TTM) vs TTM 1 Yr. Ago | -24.00 | -- | -- | |
EPS - 5 Yr. Growth Rate | -- | 11.98 | 10.85 | |
Capital Spending - 5 Yr. Growth Rate | -- | 9.07 | 15.20 |
Financial Strength
Company | industry | sector | |
---|---|---|---|
Quick Ratio (MRQ) | -- | 2.24 | 2.25 |
Current Ratio (MRQ) | 8.22 | 3.50 | 3.08 |
LT Debt to Equity (MRQ) | 16.54 | 18.65 | 11.38 |
Total Debt to Equity (MRQ) | 16.54 | 31.33 | 16.12 |
Interest Coverage (TTM) | -- | -43.11 | 29.47 |
Profitability Ratios
Company | industry | sector | ||
---|---|---|---|---|
Gross Margin (TTM) | -- | 56.24 | 53.81 | |
Gross Margin - 5 Yr. Avg. | -- | 60.48 | 52.18 | |
EBITD Margin (TTM) | -3,241.64 | -- | -- | |
EBITD - 5 Yr. Avg | -- | -110.41 | 12.87 | |
Operating Margin (TTM) | -3,331.95 | -184.63 | 6.19 | |
Operating Margin - 5 Yr. Avg. | -- | -126.89 | 8.31 | |
Pre-Tax Margin (TTM) | -3,376.41 | -175.33 | 7.15 | |
Pre-Tax Margin - 5 Yr. Avg. | -- | -132.69 | 8.61 | |
Net Profit Margin (TTM) | -3,376.57 | -182.03 | 3.29 | |
Net Profit Margin - 5 Yr. Avg. | -- | -137.08 | 4.89 | |
Effective Tax Rate (TTM) | -- | 22.48 | 22.91 | |
Effective Tax Rate - 5 Yr. Avg. | -- | 15.51 | 23.38 |
Efficiency
Company | industry | sector | ||
---|---|---|---|---|
Revenue/Employee (TTM) | 10,657 | 7,654,547 | 842,388,263 | |
Net Income/Employee (TTM) | -359,831 | 562,105 | 99,841,601 | |
Receivable Turnover (TTM) | -- | 6.23 | 5.71 | |
Inventory Turnover (TTM) | -- | 1.89 | 3.47 | |
Asset Turnover (TTM) | 0.02 | 0.32 | 0.93 |
Management Effectiveness
Company | industry | sector | ||
---|---|---|---|---|
Return on Assets (TTM) | -61.65 | 6.39 | 11.06 | |
Return on Assets - 5 Yr. Avg. | -- | 5.47 | 12.20 | |
Return on Investment (TTM) | -68.51 | 8.92 | 14.45 | |
Return on Investment - 5 Yr. Avg. | -- | 6.78 | 15.87 | |
Return on Equity (TTM) | -75.74 | 10.08 | 15.96 | |
Return on Equity - 5 Yr. Avg. | -- | 8.32 | 17.00 |
1 Year | 3 Year | 5 Year | |
---|---|---|---|
Sales % | -43.49 | 150.71 | -- |
EPS (TTM) % | -87.68 | -- | -- |
Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for ProQR Therapeutics NV
Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
---|---|---|---|---|
4 Week | -13.89 | -16.86 | 11 | 99 |
13 Week | -10.58 | -14.93 | 31 | 95 |
26 Week | -4.12 | -11.41 | 47 | 98 |
52 Week | -34.87 | -44.80 | 27 | 72 |
YTD | -5.10 | -16.66 | 40 | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
% Shares Owned: | 77.16% |
# of Holders: | 86 |
Total Shares Held: | 29,076,305 |
3 Mo. Net Change: | 5,130,206 |
# New Positions: | 44 |
# Closed Positions: | 7 |
# Increased Positions: | 59 |
# Reduced Positions: | 24 |
# Net Buyers: | 35 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.